Provided by Tiger Trade Technology Pte. Ltd.

DaVita HealthCare Partners

180.68
+1.801.01%
Post-market: 180.680.00000.00%19:44 EDT
Volume:461.80K
Turnover:83.60M
Market Cap:11.60B
PE:14.90
High:182.53
Open:180.00
Low:178.80
Close:178.88
52wk High:247.49
52wk Low:101.00
Shares:64.20M
Float Shares:32.63M
Volume Ratio:0.69
T/O Rate:1.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):12.13
EPS(LYR):9.84
ROE:88.48%
ROA:7.52%
PB:-15.16
PE(LYR):18.36

Loading ...

DaVita Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 29

Will DaVita’s (DVA) Expanded Humana CKD Partnership Reshape Its Value-Based Care Narrative?

Simply Wall St.
·
Aug 27

DaVita Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 27

Press Release: Alebund Pharmaceuticals Announces 2026 Interim Results

Dow Jones
·
Aug 26

DaVita Reaches Kidney Care Agreement With Humana

MT Newswires Live
·
Aug 25

DaVita Partners with Humana on Value-Based Care Program for CKD Patients

Reuters
·
Aug 25

DaVita Announces New Value-Based Partnership with Humana to Expand Care for Patients with Chronic Kidney Disease

THOMSON REUTERS
·
Aug 25

DaVita Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 25

DaVita Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Aug 21

DaVita Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Aug 18

Alphabet Becomes Berkshire Hathaway's Third-Largest Investment

Reuters
·
Aug 15

DaVita Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 14

Truist Financial Remains a Hold on DaVita (DVA)

TIPRANKS
·
Aug 13

NYSE Order Imbalance 128806.0 Shares on Buy Side

THOMSON REUTERS
·
Aug 13

DaVita Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 12

Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS), Lifestance Health Group (LFST) and DaVita (DVA)

TIPRANKS
·
Aug 11

DaVita Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 08

DaVita is Maintained at Hold by Truist Securities

Dow Jones
·
Aug 07

Truist Adjusts Price Target on DaVita to $215 From $250, Maintains Hold Rating

MT Newswires Live
·
Aug 07

CytoSorbents Q2 Adjusted Loss Narrows on Cost Controls

Reuters
·
Aug 07